Leonard V. D. B.
- Country
- The Netherlands
- Department
- ALS Centrum, Divisie Hersenen
Research Overview
- Phase 1b Open-Label Study of VRG50635 in Sporadic and Familial Amyotrophic Lateral Sclerosis Patients with Long-Term Treatment
- Safety and Tolerability Evaluation of QRL-201 in Patients with Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
- Multiple Ascending Dose Evaluation of LY4256984 in Patients with Sporadic Amyotrophic Lateral Sclerosis
Data & Insights
Has run more than one trial at 38 of 83 partner sites.
Specializations
Neurodegenerative Disease Research
This investigator specializes in studying Amyotrophic Lateral Sclerosis (ALS), with particular emphasis on developing therapeutic interventions for both sporadic and familial forms of the disease.
- Disease Progression Assessment
- Survival Rate Analysis
- Respiratory Function Monitoring
Their research extends to specific genetic variants, including FUS mutations in ALS.
Clinical Trial Innovation
The investigator conducts extensive research into novel therapeutic approaches for neurodegenerative conditions, evaluating multiple experimental treatments for ALS.
- Treatment Efficacy Assessment
- Safety Profile Evaluation
- Long-term Patient Outcomes
Their work includes studying interventions targeting various aspects of ALS pathophysiology.
Therapeutic Development
The investigator focuses on evaluating innovative therapeutic compounds and their effects on clinical functioning in ALS patients.
- Disease Modification Strategies
- Biomarker Analysis
- Treatment Response Monitoring
Their research encompasses both single-dose and multiple-dose therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.